KunWha Pharmaceutical Co., Ltd. (KOSE:A002250) has been chosen as the preferred bidder to buy Hanwha Corp.'s (KOSE:A000880) Dream Pharma Corp., according to sources on July 3, 2014. Kunwha Pharmaceuticals will exercise its right to enter into exclusive negotiations for two weeks.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27,050 KRW | +1.88% | +5.87% | +5.05% |
05-22 | Hanwha Group Names New Head of North American Investments | MT |
05-16 | White House moves to protect US solar manufacturers from Chinese competition | RE |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.05% | 1.45B | |
+13.63% | 78.89B | |
+9.44% | 51.46B | |
+8.93% | 51.07B | |
+20.90% | 46.59B | |
+16.04% | 43.21B | |
+24.52% | 39.69B | |
-0.60% | 29.1B | |
-6.79% | 27.94B | |
-14.56% | 26.05B |
- Stock Market
- Equities
- A000880 Stock
- News Hanwha Corporation
- Kunwha Reportedly Named As Preferred Bidder For Dream Pharma